
AEON Biopharma, Inc. — Investor Relations & Filings
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company focused exclusively on developing therapeutic applications for botulinum toxins. The company is advancing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA), for the treatment of debilitating nervous system-related and neuromuscular disorders. Its lead clinical programs are investigating ABP-450 for the prevention of chronic and episodic migraines and the treatment of cervical dystonia. By concentrating solely on therapeutic indications, AEON aims to unlock the full potential of neurotoxins to provide lasting relief for patients with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | |
| DEF 14A - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | |
| 4 - AEON BIOPHARMA, INC. (0001837607) (Filer) | 2026-02-20 | English | |
| 424B3 Filing | 2026-02-18 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 46344664 | 10-Q | 2026-05-14 | English | ||
| 46257361 | 8-K | 2026-05-14 | English | ||
| 38833816 | ARS - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | ||
| 38832256 | DEF 14A - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-04-29 | English | ||
| 32899519 | 4 - AEON BIOPHARMA, INC. (0001837607) (Filer) | 2026-02-20 | English | ||
| 32002100 | 424B3 Filing | 2026-02-18 | English | ||
| 18394499 | S-3 - AEON Biopharma, Inc. (0001837607) (Filer) | 2026-02-09 | English | ||
| 32002215 | SCHEDULE 13D/A Filing | 2026-01-29 | English | ||
| 32002182 | 3 Filing | 2026-01-29 | English | ||
| 32002083 | SCHEDULE 13D Filing | 2026-01-29 | English | ||
| 13355752 | 8-K | 2026-01-21 | English | ||
| 13355753 | 8-K | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 13355754 | DEF 14A | 2025-12-29 | English | ||
| 13355756 | PRE 14A | 2025-12-19 | English | ||
| 13355755 | 8-K | 2025-12-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
AEON Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35234/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35234 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35234 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35234 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35234}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AEON Biopharma, Inc. (id: 35234)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.